PharmaTalkRadio

In an increasingly competitive market, there is a growing need for efficiency in attracting and retaining top talent.

This session, recorded at the 7th annual Chief Medical Officer Summit, and moderated by Dr Julie Krop, AMAG Pharmaceuticals, addresses the following:

How to source talent; pros and cons of recruiters versus word-of-mouthHow to make the work environment optimal to keep employees satisfiedHow to compete with the competition banging on the doorHow to ease or address relocation concerns of potential hiresWhen is a good time to have consultants or contractors filling the gapsHow to access the untapped talent in academia, do they know we exist?Benefit/risk of having non-MDs fill the gaps and guided by a physicianDoes the industry need to evolve to attract and retain talentHow do you decide whom to recruit firstHow to identify the right hire

Panelists include:

Kara Coluccio Bern, Perspective GroupJames Lewis, Barrington JamesChris Poshka, Govig

Learn more at theconferenceforum.org

First recorded at the 7th annual Chief Medical Officer Summit, this session provides insight in what it takes and how to navigate and what to expect in the CEO role. Moderated by Dr Zain Kassam, Finch Therapeutics, this panel discusses:

How can a CMO position themselves as a corporate leader?How to build a network of advisors and who should it include?

Panelists include:

Aoife Brennan, MB, BCh, BAO, MRCPI, SynlogicGreg Fiore, MD, Sollis Therapeutics

Learn more at theconferenceforum.org

In this podcast, hear a session from the 2019 Patients as Partners EU conference on How do Patients Become Partners in the Sharing of Data to Advance Science?

How to encourage the sharing of suitably anonymized data to further medicines development for the benefit of patients?What are the barriers/issues? Public mistrust of pharma? Language, medical records versus coded data?

Speakers:

Natalie Banner, PhD, Understanding Patient Data Lead, Wellcome Trust

Richard Stephens, Patient/Consumer Lead, Chair Consumer Forum, NCRI

 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.

In this podcast, hear a panel discussion presented at the 2019 Patients as Partners EU conference on Best Practices for Pharma - Patient Advocacy Partnerships.  Pharma and advocacy representatives discuss:

• Advocacy point of view on is what pharma is doing in clinical trials and medicines development truly patient-centric?

• How can advocacy groups work with the pharmaceutical industry to improve the clinical trial process?

• How can advocacy get their foot in the door at pharma? Pharma’s advice.

• How can pharma and advocacy better work together?

• Explore the value of pharma reps spending time at an advocacy office to better understand what they do

• How can this partnership impact patients and medicines development?

Moderator:

Chris Macdonald, Head of Research, Pancreatic Cancer UK

Panelists:

Vanessa Pott, Director, Patient Advocacy & Strategic Partnerships, Merck KGaA

Natasha Ratcliffe, PhD, Research Involvement Manager, Parkinson’s UK

 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the conference and patient centricity in R&D, visit theconferenceforum.org.

In this podcast, hear a session from the 2019 Patients as Partners EU meeting where Merck's Vanessa Pott presented a case study on Innovative Medicines Development and Merck KGaA's next phase of Patient Centricity in R&D. 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.

In this talk, recorded at the 5th annual IO360° Summit, Dr Alex Minella, Amgen, provides a clinical update on AMG 420, an anti-BCMA BiTE®

This talk addresses the:

Summary of IND enabling preclinical studiesFirst-in-human trial designFirst-in-human trial data (safety, efficacy)

Save the date for the 6th annual Immuno-Oncology 360° Summit on February 26-28, 2020 at the Crowne Plaza Times Square in New York City. Learn more at www.io360summit.com

At the 2019 Patients as Partners EU meeting, Servier's Lode Dewulf presented a discussion on connecting employee-centric culture to patient-centric culture. This presentation covered the following points:

• What impact can engaged employees have on positioning the company as the preferred partner for patients and other collaborators?

• How can this be done? And for what purpose?

• How do you engage your employees and empower them to implement patient involvement strategies?

• Inspiring employees to make change?

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020.

To learn more about patient centricity in drug development and R&D and the Patients as Partners EU program, visit theconferenceforum.org.

In this podcast, listen to a session from the 2019 Patients as Partners EU conference on Sanofi Eliciting Patient Experience Data During Clinical Trials to Better Understand Patient-Perceived Benefits and Disadvantages of their Drugs.

Dr Aude Roborel de Climens, PRO/COA Lead at Sanofi discusses how they capture patient experiences during clinical research and the benefit of collecting direct patient feedback. More specifically, she presents how they evaluate and analyse qualitatively and quantitatively individual patient experiences of benefits and risks of drugs during clinical trials to better understand and support clinical results and help future design of patient support programs.

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.

In this podcast, hear a session presented at the 2019 Patients as Partners EU conference on the Process to Understand the Language of Patients and the Value of Health Literacy.

Who is responsible for delivering the why and how of getting involved in medicines development? Pharma, regulators or advocacy groups?What practical goals can the industry set to effect change?How are we communicating the trial information to patients and care partners to help them understand and make informed decisions?How can we address the communication challenges faced by patients and care partners while navigating the systemConsiderations for language used in adverse events reporting, informed consent and clinical trial summaries

Speaker:

James (Jay) Duhig, PhD, Director, Patient Integration, Pharmacovigilance and Patient Safety (PPS), AbbVie

 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the Patients as Partners EU program and patient centricity in R&D, visit theconferenceforum.org.

In this podcast, hear a case study from the 2019 Patients as Partners EU conference on UCB and Parkinson's UK Working Together to Improve a Phase 2 Trial through Patient Involvement.

In 2018, UCB and Parkinson’s UK co-developed a workshop to enable the UCB research team to work together with people affected by Parkinson’s to discuss and develop a potential phase 2 clinical trial. The aim of the workshop was to better understand people’s thoughts on clinical trials and get feedback on key features of the potential trial to maximise appropriateness, acceptability and success. In this session, attendees hear a multi-stakeholder perspective on the collaboration, including:

• How the workshop was co-developed

• Benefits and impact of patient involvement

• Key challenges and solutions during the collaboration

• Practical tips for industry and patient organisation collaborations

Speakers:

Natasha Ratcliffe, PhD, Research Involvement Manager, Parkinson’s UK

Elaine Sutcliffe, Patient Advocate

Kate Trenam, UK Patient Advocacy and Policy Manager, UCB

 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about patient centricity in R&D and the Patients as Partners EU program, visit theconferenceforum.org.